Finnrick - Ensuring a Safer and More Transparent Supply Chain
Laicuinuo LCN

Laicuinuo LCN

Retatrutide

Finnrick tested 6 samples of Retatrutide (GLP-1, GIP, and GCGR agonist) from Laicuinuo LCN between 10 Sep 2025 and 19 Mar 2026. Test scores average over 6, no score below 5, and at least 6 tests warrant a confident Finnrick Rating of B (Good).

Finnrick Rating™
Laicuinuo LCN
Retatrutide
Tested 6 Samples
Last test 19 Mar 2026

Take Action

Researcher

Request Full Data Access to the Finnrick database of peptide tests.

Free peptide testing

Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.

Other Retatrutide tests from top-rated vendors:

All Retatrutide tests from Laicuinuo LCN

Samples are tested in commercial labs

Tests Count

6

Scores

AVG8.1MIN5.9MAX9.7

Last

19 Mar 2026

First

10 Sep 2025
Quantity
Test DateCertificate
Test Score
LabelTestedDifferencePurityBatch IDContainerTested AtSent By
19 Mar 2026View9.220mg18.5mg-7.5%99.90%November 2 2025(no data)Lab EPublic
19 Mar 2026View5.910mg8.75mg-12.5%99.90%(no batch ID)White Label / Silver Crimp / Green CapLab EPublic
20 Feb 2026View7.510mg11.2mg+12.0%99.70%12/15/2025White Label / Silver Crimp / Green CapLab GPublic
18 Nov 2025View9.75mg5.1mg+2.0%99.76%250904-VIN-001No Label / Silver Crimp / Blue Cap Lab EPublic
17 Oct 2025View9.610mg9.68mg-3.2%99.74%RT10No Label / Silver Crimp / Yellow Cap Lab EPublic
10 Sep 2025View7.010mg10.8mg+8.0%99.95%(no batch ID)No Label / Silver Crimp / Yellow CapLab EPublic